Check if your research matches the topics covered in PSORIASIS-TARGETS AND THERAPY?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Sign up now and unlock a detailed chart of Time to publish for this journal
Indexed in the following public directories
Overview | |
Publisher | DOVE MEDICAL PRESS LTD |
Language | English |
Frequency | Continuous publication |
Article Processing Charges | USD 2390 |
Publication Time | 16 |
Editorial Review Process | Anonymous peer review |
General Details | |
Language | English |
Frequency | Continuous publication |
Publication Start Year | 2011 |
Publisher URL | Visit website |
Website URL | Visit website |
Publication Details | |
Editorial Review Detail | |
Information for authors | |
Author instructions | Visit website |
Copyright Details | Visit website |
Deposit Policy | Sherpa/Romeo |
License type | CC BY, CC BY-NC |
OA statement | Visit website |
Upload your Manuscript to get
147 articles received 1.9K citationssee all
PSORIASIS-TARGETS AND THERAPY has been in operation since 2011 till date.
PSORIASIS-TARGETS AND THERAPY published with a Continuous publication frequency.
In 2023, PSORIASIS-TARGETS AND THERAPY publsihed 7 articles.
For PSORIASIS-TARGETS AND THERAPY, eISSN is 2230-326X and pISSN is 2230-326X.
DOVE MEDICAL PRESS LTD is the publisher of PSORIASIS-TARGETS AND THERAPY.